Ikarian Capital, LLC Abb Vie Inc. Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $18 Million - $20.3 Million	131,175 Added 9900.0%	132,500 $20.5 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $177,006 - $204,911	1,325 New	1,325 $197,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $11 Million - $14.7 Million	-150,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $9.68 Million - $14.7 Million	150,000 New	150,000 $11.4 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.